AC Immune SA Holds Annual Shareholder Meeting, Votes on Agenda Items
Ticker: ACIU · Form: 6-K · Filed: Jun 20, 2025 · CIK: 1651625
| Field | Detail |
|---|---|
| Company | Ac Immune SA (ACIU) |
| Form Type | 6-K |
| Filed Date | Jun 20, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-meeting, corporate-governance, voting-results
TL;DR
AC Immune SA shareholders met June 19th, voted on agenda items, with two items withdrawn by the board.
AI Summary
On June 19, 2025, AC Immune SA held its Annual General Meeting of Shareholders. The company announced the final voting results on the agenda items, with the Management presentation attached as Exhibit 99.1. Notably, the board of directors withdrew agenda items 6.1 and 6.2 prior to the meeting.
Why It Matters
Shareholder meetings are crucial for corporate governance, allowing investors to vote on key company matters and influencing the direction of the company.
Risk Assessment
Risk Level: low — This filing is a routine update on a shareholder meeting and does not contain significant new financial or operational information.
Key Players & Entities
- AC Immune SA (company) — Registrant
- June 19, 2025 (date) — Date of Annual General Meeting
- Exhibit 99.1 (document) — Attached Management Presentation
FAQ
What was the purpose of the Form 6-K filing?
The Form 6-K filing was made to report the final results of the voting on agenda items at AC Immune SA's Annual General Meeting of Shareholders held on June 19, 2025.
When did AC Immune SA hold its Annual General Meeting of Shareholders?
AC Immune SA held its Annual General Meeting of Shareholders on June 19, 2025.
Were all agenda items presented for a vote at the meeting?
No, the board of directors of AC Immune SA withdrew agenda items 6.1 and 6.2 prior to the meeting.
What is attached to this filing?
The Management presentation to shareholders is attached hereto as Exhibit 99.1.
Where is AC Immune SA's principal executive office located?
AC Immune SA's principal executive offices are located at EPFL Innovation Park Building B, 1015 Lausanne, Switzerland.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 20, 2025 regarding AC Immune SA (ACIU).